Exane Derivatives’s iShares MSCI Australia ETF EWA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1
Closed -$23 644
2017
Q1
$23 Sell
1
-513
-100% -$11.2K ﹤0.01% 545
2016
Q4
$10.4K Sell
514
-1,242
-71% -$25.6K ﹤0.01% 395
2016
Q3
$36.7K Sell
1,756
-11,034
-86% -$225K 0.01% 323
2016
Q2
$245K Buy
12,790
+476
+4% +$9.29K 0.04% 191
2016
Q1
$238K Buy
12,314
+7,271
+144% +$131K 0.03% 182
2015
Q4
$95.6K Sell
5,043
-8,632
-63% -$163K 0.01% 212
2015
Q3
$245K Buy
+13,675
New +$268K 0.03% 173

Other funds holding EWA

Exane Derivatives's EWA Position: Q2 2017 in Review

Exane Derivatives sold out of iShares MSCI Australia ETF (EWA) in Q2 2017, closing a stake of 1 share — an estimated $23 sold.

Exane Derivatives first reported a position in EWA in Q3 2015 and held it in 7 quarters. The position peaked at $245K in Q3 2015. 179 funds tracked by Wall St. Rank hold EWA as of Q2 2017.

  • Exane Derivatives reported no remaining iShares MSCI Australia ETF position as of Q2 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 iShares MSCI Australia ETF share in Q2 2017, an estimated $23.
  • Exane Derivatives first reported a position in iShares MSCI Australia ETF in Q3 2015 and held it in 7 quarters.
  • Exane Derivatives's iShares MSCI Australia ETF position peaked at $245K in Q3 2015.
  • 179 funds tracked by Wall St. Rank held iShares MSCI Australia ETF as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.